characteristics.text: SAMN34238671
characteristics.characteristic: External Id
characteristics.text: Biomedical Engineering, Yale University
characteristics.characteristic: INSDC center name
characteristics.text: 2023-04-19T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-04-19T14:57:07.530Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS17348099
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS17348099
characteristics.characteristic: SRA accession
characteristics.text: Mus musculus
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_10090
characteristics.characteristic: organism
characteristics.text: skin
characteristics.characteristic: source_name
characteristics.text: C57BL/6J
characteristics.characteristic: strain
characteristics.text: 8 days post-tumor initiation
characteristics.characteristic: time
characteristics.text: skin
characteristics.characteristic: tissue
characteristics.text: YUMMER1.7 (YR) tumor (8 days post-tumor initiation, either untreated or 24 hours post-treatment), scRNA-seq
characteristics.characteristic: title
characteristics.text: untreated, or treated with the combination of anti-PD-1, CSF1R blockade, and agonistic CD40 (i.e., TTx) by i.p. injection 24 hours prior to collection for sequencing (treatment distinguished by metadata in labels.txt file)
characteristics.characteristic: treatment